BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7038152)

  • 1. Cell culture of Peyronie's disease plaque and normal penile tissue.
    Somers KD; Dawson DM; Wright GL; Leffell MS; Rowe MJ; Bluemink GG; Vande Berg JS; Gleischman SH; Devine CJ; Horton CE
    J Urol; 1982 Mar; 127(3):585-8. PubMed ID: 7038152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor expression in Peyronie's disease.
    Mulhall JP; Thom J; Lubrano T; Shankey TV
    J Urol; 2001 Feb; 165(2):419-23. PubMed ID: 11176387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation increases fibrogenic cytokine expression by Peyronie's disease fibroblasts.
    Mulhall JP; Branch J; Lubrano T; Shankey TV
    J Urol; 2003 Jul; 170(1):281-4. PubMed ID: 12796706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbation of cell cycle regulators in Peyronie's disease.
    Mulhall JP; Branch J; Lubrano T; Shankey TV
    Int J Impot Res; 2001 Dec; 13 Suppl 5():S21-8. PubMed ID: 11781743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses.
    Mulhall JP; Anderson MS; Lubrano T; Shankey TV
    Int J Impot Res; 2002 Oct; 14(5):397-405. PubMed ID: 12454692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model.
    Mulhall JP; Martin DJ; Lubrano T; Moser M; Kwon E; Wojcik E; Shankey TV
    Int J Impot Res; 2004 Apr; 16(2):99-104. PubMed ID: 14973530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphological characteristics of Peyronie's disease].
    Kapuller LL; Derevianko VP; Novak GIa; Bukhman AA
    Arkh Patol; 1982; 44(10):49-54. PubMed ID: 7181709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome abnormalities in Peyronie's disease.
    Somers KD; Winters BA; Dawson DM; Leffell MS; Wright GL; Devine CJ; Gilbert DA; Horton CE
    J Urol; 1987 Apr; 137(4):672-5. PubMed ID: 3560320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron microscopic study of the penile plaques and adjacent corpora cavernosa in Peyronie's disease.
    Hirano D; Takimoto Y; Yamamoto T; Hirakata H; Kawata N
    Int J Urol; 1997 May; 4(3):274-8. PubMed ID: 9255666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease.
    Mulhall JP; Nicholson B; Pierpaoli S; Lubrano T; Shankey TV
    Int J Impot Res; 2004 Jun; 16(3):288-93. PubMed ID: 14961053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of calcification in Peyronie's disease.
    Vande Berg JS; Devine CJ; Horton CE; Somers KD; Wright GL; Leffell MS; Dawson DM; Gleischman SH; Rowe MJ
    J Urol; 1982 Jan; 127(1):52-4. PubMed ID: 7057504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin deposition in Peyronie's disease plaque.
    Somers KD; Dawson DM
    J Urol; 1997 Jan; 157(1):311-5. PubMed ID: 8976287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could plaque excision surgery with sis graft induce a new fibrotic reaction in la Peyronie's disease patients?
    Rolle L; Tamagnone A; Bollito E; Ceruti C; Timpano M; Negro CL; Galletto E; Fontana D
    Arch Ital Urol Androl; 2007 Dec; 79(4):167-9. PubMed ID: 18303735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease.
    Haag SM; Hauck EW; Szardening-Kirchner C; Diemer T; Cha ES; Weidner W; Eickelberg O
    Eur Urol; 2007 Jan; 51(1):255-61. PubMed ID: 16782264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents.
    Anderson MS; Shankey TV; Lubrano T; Mulhall JP
    Int J Impot Res; 2000 Sep; 12 Suppl 3():S25-31. PubMed ID: 11002396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunological features of Peyronie's disease.
    Ralph DJ; Mirakian R; Pryor JP; Bottazzo GF
    J Urol; 1996 Jan; 155(1):159-62. PubMed ID: 7490821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peyronie's disease and mechanotransduction: an in vitro analysis of the cellular changes to Peyronie's disease in a cell-culture strain system.
    Chung E; De Young L; Solomon M; Brock GB
    J Sex Med; 2013 May; 10(5):1259-67. PubMed ID: 23421851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peyronie's disease.
    Pryor J; Akkus E; Alter G; Jordan G; Lebret T; Levine L; Mulhall J; Perovic S; Ralph D; Stackl W
    J Sex Med; 2004 Jul; 1(1):110-5. PubMed ID: 16422991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.